Koyfin Home > Directory > Health Care > Abeona Therapeutics > Total Debt / (EBITDA-CAPEX)

Abeona Therapeutics Total Debt / (EBITDA-CAPEX) Chart (ABEO)

Abeona Therapeutics annual/quarterly Total Debt / (EBITDA-CAPEX) from 2010 to 2020.
  • Abeona Therapeutics Total Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $0m a 35.42% decrease of 0m year over year
  • Abeona Therapeutics Total Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $0m a 36.48% decrease of 0m year over year
  • Abeona Therapeutics Annual Total Debt / (EBITDA-CAPEX) for 2019 was $0m a -18.58% increase of 0m from 2018
  • Abeona Therapeutics Annual Total Debt / (EBITDA-CAPEX) for 2014 was $0m a -179.19% increase of 0m from 2013
  • Abeona Therapeutics Annual Total Debt / (EBITDA-CAPEX) for 2011 was $0m a -104.17% increase of 0m from 2010
Other Ratios Metrics:
  • Abeona Therapeutics Total Debt / Capital for the quarter ending December 12, 2014 was $8m a -1,061.80% decrease of -81m year over year
  • Abeona Therapeutics Other Liabilities for the quarter ending December 12, 2017 was $3m a -14.77% decrease of 0m year over year
  • Abeona Therapeutics Total Debt / Equity for the quarter ending December 12, 2014 was $8m a -36,027.59% decrease of -2,992m year over year
View Chart On Koyfin

Quarterly ABEO Total Debt / (EBITDA-CAPEX) Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2014$0m
09/2014$0m
09/2012$-1m
06/2012$0m

Annual ABEO Total Debt / (EBITDA-CAPEX) Data

2019$0m
2014$0m
2011$0m
2010$-1m